Showing results (461-470 of 523) with videos related to

Sort By:
Pageof 53
Pediatric Research|October 8, 2021
Neonatal encephalopathy plasma metabolites are associated with neurodevelopmental outcomesBarbara D Friedes, Eleanor Molloy, Tammy Strickland, et al.
Cardiology in the Young|August 25, 2017
Impaired cerebral autoregulation and elevation in plasma glial fibrillary acidic protein level during cardiopulmonary bypass surgery for CHDRonald B Easley, Bradley S Marino, Jacky Jennings, et al.
Pediatric Pulmonology|July 11, 2012
Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasiaJoseph M Collaco, Lewis H Romer, Bridget D Stuart, et al.
The Journal of Pediatrics|July 2, 2020
Plasma and Cerebrospinal Fluid Candidate Biomarkers of Neonatal Encephalopathy Severity and Neurodevelopmental OutcomesBarbara Dietrick, Eleanor Molloy, An N Massaro, et al.
Human & Experimental Toxicology|December 28, 2000
Prospects for reducing and refining the use of dogs in the regulatory toxicity testing of pharmaceuticalsC L Broadhead, G Betton, R Combes, et al.
Chest|January 29, 2020
Noninvasive Prognostic Biomarkers for Left-Sided Heart Failure as Predictors of Survival in Pulmonary Arterial HypertensionCatherine E Simpson, Rachel L Damico, Paul M Hassoun, et al.
American Journal of Respiratory Cell and Molecular Biology|June 11, 2024
Collagen 18A1/Endostatin Expression in the Progression of Right Ventricular Remodeling and Dysfunction in Pulmonary Arterial HypertensionAnjira S Ambade, Mario Naranjo, Tijana Tuhy, et al.
Pulmonary Circulation|May 4, 2022
Hepatoma-derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survivalJun Yang, Anjira S Ambade, Melanie Nies, et al.
Pulmonary Circulation|September 7, 2023
Low-affinity insulin-like growth factor binding protein 7 and its association with pulmonary arterial hypertension severity and survivalGuillermo Torres, Andrew C Lancaster, Jun Yang, et al.
Pageof 53